Medscape3d
Educating Patients in Self-Management of Epistaxis in an Anticoagulation Clinic
Karen L. Hassenplug, Pharm.D.; Jill S. Burkiewicz, Pharm.D., BCPS; Terri L. Jackson, Ph.D., B.S.Pharm.; Laura R. Peppers, Pharm.D., BCPS Identifying baseline ...
pharmaphorum22h
FDA experts lukewarm on AZ's anticoagulant antidote Andexxa
AstraZeneca's anticoagulant reversal agent Andexxa was given an accelerated approval by the FDA in 2018, but the company's plan to get that upgraded to a full approval is facing some pushback.
jnis.bmj3d
Antiplatelets and antithrombotics in neurointerventional procedures: Guideline update
(7) For patients with unruptured brain arteriovenous malformations there is no indication to change antiplatelet or anticoagulant management instituted for management of another disease (Class IIb, ...
BMJ6d
Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study
Background Despite simpler regimens than vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF), adherence (taking drugs as prescribed) and persistence (continuation of drugs) ...